SOURCE THC BioMed
THC BioMed is pleased to report that it has acquired all regulatory permissions to begin the production of its Pure Cannabis Sticks and THC Kiss.
THC BioMed’s consulting engineers and Quality Assurance team are currently monitoring initial production of the Pure Cannabis Sticks and fine tuning the automated production machine for product quality. Images of our end product will be posted on the Company’s website.
Pure Cannabis Sticks have biodegradable filters and are expected to be sold in packs of 1, 4, and 25.
THC Kiss, THC BioMed’s cannabis beverage, also has gone into production and will be distributed to medical patients first with the roll out extending to the provinces shortly thereafter.
THC expects to release THC Kiss for sale to medical patients within the next 30 days.
About THC BioMed
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. THC BioMed is Canada’s largest supplier of legal cannabis genetics. The Company is on the leading edge of scientific research and the development of products and services related in the medical cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements by the use of words such as “will,” “may,” “would,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “could” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this release are made as of the date of this press release and include that (a) Pure Cannabis Sticks will be sold in packs of 1, 4, and 25, (b) THC Kiss will be released to medical patients in the next 30 days, with the roll out extending to the provinces shortly thereafter, and (c) THC BioMed will be on the forefront of this rapidly growing industry. Although THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC can give no assurance that they will prove to be correct. THC BioMed disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
For further information:
President and CEO: John Miller, THC Biomed Intl Ltd., T: 1-844-THCMEDS, E: [email protected]